Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$13.45
+$0.27 (+2.05%)
At close: Oct 30, 2026, 4:00 PM ET
$13.79
+$0.34 (+2.53%)
Pre-market:
Nov 2, 2026, 7:12 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q1 2025 Mar 31, 2025 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.5M | -3.75M | -1.71M | -3.59M | -4.34M | -6.23M | -7.51M | -10.62M | -11.62M | -12.09M | -9.89M | -36.06M | -8.69M |
Depreciation & Amortization | n/a | n/a | n/a | 188K | 185K | 186K | 189K | 129K | 198K | 202K | 279K | 331K | 148K |
Stock-Based Compensation | 95K | 46K | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 645K | -2.01M | 412K | -282K | 742K | -1.32M | -91K | 937K | -910K | 965K | -241K | -878K | -561K |
Other Non-Cash Items | -245K | -49K | 261K | 204K | 661K | 1.14M | 803K | 775K | 1.32M | 1.72M | 1.77M | 26.89M | 1.42M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -137K | -1.7M | 2.63M | -250K | 1.43M | -1.91M | -430K | -33K | 615K | 235K | 244K | -957K | -557K |
Operating Cash Flow | -4.79M | -5.45M | 1.2M | -3.45M | -2.07M | -6.81M | -6.95M | -9.75M | -9.49M | -9.93M | -7.59M | -9.8M | -7.69M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -48K | -7K | -11K | -20K | -69K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | 233K | 14K | 11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.15M | n/a |
Investing Cash Flow | n/a | n/a | n/a | 233K | 14K | 11K | -48K | -7K | -11K | -20K | -69K | 2.15M | n/a |
Debt Repayment | n/a | n/a | -865K | -220K | n/a | -7.5M | n/a | n/a | n/a | -36K | 3.03M | -1.25M | -1.25M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 60.3M | 6.99M | n/a | 2.17M | n/a | n/a | 1.5M | n/a | 7M | -124K | 311K | -143K | 2.51M |
Financial Cash Flow | 60.39M | 7.03M | -865K | 3.67M | 1.43M | -7.5M | 1.5M | n/a | 7M | -160K | 3.36M | 46.33M | 1.26M |
Net Cash Flow | 55.6M | 1.38M | 339K | 453K | -624K | -14.3M | -5.49M | -9.75M | -2.5M | -10.11M | -4.3M | 38.68M | -6.42M |
Free Cash Flow | -4.79M | -5.45M | 1.2M | -3.45M | -2.07M | -6.81M | -6.99M | -9.75M | -9.5M | -9.95M | -7.66M | -9.8M | -7.69M |
Adj. Free Cash Flow | -4.88M | -5.5M | 1.18M | -3.45M | -2.07M | -6.81M | -6.99M | -9.75M | -9.5M | -9.95M | -7.66M | -9.8M | -7.69M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -48K | -7K | -11K | -20K | -69K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -4.79M | -5.45M | 1.2M | -3.45M | -2.07M | -6.81M | -6.99M | -9.75M | -9.5M | -9.95M | -7.66M | -9.8M | -7.69M |
Add to Watchlist
Select watchlists to add or remove ELOX